Email alerts
Advanced Search
  • Aug 21, 2012
    Medtronic Reports First Quarter Earnings
    Revenue of $4.0 Billion Grew 5% on a Constant Currency Basis; 2% as Reported

    MINNEAPOLIS - August 21, 2012 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its first quarter of fiscal year 2013, which ended July 27, 2012. The Company reported worldwide...

  • Jun 21, 2012
    Medtronic Stent Graft Chosen by U.S. FDA for Innovative Program
    Regulatory Agency Selects Investigational Medical Device for Endovascular Treatment of Thoracic Aortic Aneurysms Involving Branch Vessel for Early Feasibility Pilot Program

    MINNEAPOLIS -- June 21, 2012 -- The U.S. Food and Drug Administration (FDA) recently selected a stent graft being developed by Medtronic, Inc. (NYSE: MDT) for an early feasibility pilot program...

  • Jun 21, 2012
    Medtronic Increases Its Cash Dividend by 7 Percent

    MINNEAPOLIS - June 21, 2012 - The board of directors of Medtronic, Inc. (NYSE: MDT) today approved a 7.2 percent increase in its cash dividend for fiscal year 2013, raising the quarterly amount to...

  • Jun 8, 2012
    Medtronic Files PMA Application for FDA Approval of MiniMed 530G System Featuring Threshold Suspend Automation
    FDA to Review World's First Insulin Pump with Threshold Suspend - Another Significant Step Toward the Artificial Pancreas

    MINNEAPOLIS - June 8, 2012 -In the next step toward the development of an artificial pancreas, Medtronic, Inc. (NYSE:MDT) today announced that it has filed the final module of its Pre-Market...

  • May 31, 2012
    Medtronic CEO Omar Ishrak to Speak at Goldman Sachs Healthcare Conference

    MINNEAPOLIS--(BUSINESS WIRE)--May. 31, 2012-- Medtronic, Inc. (NYSE: MDT), the world’s leading medical technology company, today announced it will participate in the Goldman Sachs 33rd Annual...

Show 5102550100 per page